REMEDY Stock Overview
Remedy Entertainment Oyj, a video game company, engages in the development and sale of games for PC and console platforms in Finland.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Remedy Entertainment Oyj Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €16.52 |
| 52 Week High | €30.65 |
| 52 Week Low | €15.66 |
| Beta | 0.49 |
| 1 Month Change | 1.72% |
| 3 Month Change | -32.85% |
| 1 Year Change | -28.48% |
| 3 Year Change | -62.83% |
| 5 Year Change | 106.50% |
| Change since IPO | 146.94% |
Recent News & Updates
Recent updates
Analyst Forecasts Just Got A Lot More Bearish On Remedy Entertainment Oyj (HEL:REMEDY)
Feb 20
Health Check: How Prudently Does Remedy Entertainment Oyj (HEL:REMEDY) Use Debt?
Oct 27Calculating The Intrinsic Value Of Remedy Entertainment Oyj (HEL:REMEDY)
Sep 15Does Remedy Entertainment Oyj (HEL:REMEDY) Have A Healthy Balance Sheet?
Apr 05Remedy Entertainment Oyj (HEL:REMEDY) Just Reported And Analysts Have Been Cutting Their Estimates
Feb 15The Returns On Capital At Remedy Entertainment Oyj (HEL:REMEDY) Don't Inspire Confidence
Apr 29Remedy Entertainment Oyj (HEL:REMEDY) Has A Pretty Healthy Balance Sheet
Mar 07Remedy Entertainment Oyj (HEL:REMEDY) Shares Could Be 35% Below Their Intrinsic Value Estimate
Feb 16Investors Could Be Concerned With Remedy Entertainment Oyj's (HEL:REMEDY) Returns On Capital
Dec 30Do Remedy Entertainment Oyj's (HEL:REMEDY) Earnings Warrant Your Attention?
May 22Estimating The Intrinsic Value Of Remedy Entertainment Oyj (HEL:REMEDY)
May 04Investors Who Bought Remedy Entertainment Oyj (HEL:REMEDY) Shares Three Years Ago Are Now Up 557%
Mar 07Remedy Entertainment Oyj (HEL:REMEDY) Seems To Use Debt Rather Sparingly
Feb 16Should You Rely On Remedy Entertainment Oyj's (HEL:REMEDY) Earnings Growth?
Feb 04Calculating The Fair Value Of Remedy Entertainment Oyj (HEL:REMEDY)
Jan 19Under The Bonnet, Remedy Entertainment Oyj's (HEL:REMEDY) Returns Look Impressive
Jan 05
Is Now The Time To Put Remedy Entertainment Oyj (HEL:REMEDY) On Your Watchlist?
Dec 21Did You Miss Remedy Entertainment Oyj's (HEL:REMEDY) Whopping 388% Share Price Gain?
Dec 06Remedy Entertainment Oyj (HEL:REMEDY) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
Nov 20Shareholder Returns
| REMEDY | FI Entertainment | FI Market | |
|---|---|---|---|
| 7D | -0.4% | 2.5% | 1.4% |
| 1Y | -28.5% | 8.3% | -12.9% |
Return vs Industry: REMEDY underperformed the Finnish Entertainment industry which returned 8.3% over the past year.
Return vs Market: REMEDY underperformed the Finnish Market which returned -12.9% over the past year.
Price Volatility
| REMEDY volatility | |
|---|---|
| REMEDY Average Weekly Movement | 6.3% |
| Entertainment Industry Average Movement | 5.5% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in FI Market | 7.3% |
| 10% least volatile stocks in FI Market | 3.1% |
Stable Share Price: REMEDY's share price has been volatile over the past 3 months.
Volatility Over Time: REMEDY's weekly volatility (6%) has been stable over the past year, but is still higher than 75% of Finnish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | 352 | Tero Virtala | www.remedygames.com |
Remedy Entertainment Oyj, a video game company, engages in the development and sale of games for PC and console platforms in Finland. It primarily creates story-driven and visually stunning action games. The company also provides franchises under the Alan Wake, Control, and Max Payne brand names.
Remedy Entertainment Oyj Fundamentals Summary
| REMEDY fundamental statistics | |
|---|---|
| Market cap | €223.89m |
| Earnings (TTM) | -€22.66m |
| Revenue (TTM) | €33.93m |
6.6x
P/S Ratio-9.9x
P/E RatioIs REMEDY overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| REMEDY income statement (TTM) | |
|---|---|
| Revenue | €33.93m |
| Cost of Revenue | €16.84m |
| Gross Profit | €17.09m |
| Other Expenses | €39.75m |
| Earnings | -€22.66m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 29, 2024
| Earnings per share (EPS) | -1.67 |
| Gross Margin | 50.37% |
| Net Profit Margin | -66.77% |
| Debt/Equity Ratio | 1.4% |
How did REMEDY perform over the long term?
See historical performance and comparison